The negative predictive value of cervical interleukin-6 for the risk assessment of preterm birth

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 26, Issue 13, 2013, Pages 1278-1281

  Perales Puchalt, Alfredo ^a   Brik, Maia ^a   Diago, Vicente J ^a   Perales, Alfredo ^a,b  

^a HOSPITAL UNIVERSITARIO LA FE   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Cervical length; Interleukin 6; Prediction; Preterm birth

Indexed keywords

ATOSIBAN; BETAMETHASONE; INTERLEUKIN 6; NIFEDIPINE;

ADULT; ARTICLE; CERVICAL LENGTH MEASUREMENT; CONTROLLED STUDY; DISEASE COURSE; FEMALE; GESTATION PERIOD; HUMAN; MAJOR CLINICAL STUDY; OBSERVATIONAL STUDY; PREDICTIVE VALUE; PREGNANT WOMAN; PREMATURE LABOR; PREVALENCE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REPEATED DRUG DOSE; RISK ASSESSMENT; TERTIARY HEALTH CARE; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX CYTOLOGY;

ADULT; CERVIX MUCUS; FALSE POSITIVE REACTIONS; FEMALE; HUMANS; INFANT, NEWBORN; INTERLEUKIN-6; PREDICTIVE VALUE OF TESTS; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PREGNANCY TRIMESTER, THIRD; PREMATURE BIRTH; PREVALENCE; RISK ASSESSMENT; YOUNG ADULT;

EID: 84881146703     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.783798     Document Type: Article

References (27)

1. Buitendijk S, Zeitlin J, Cuttini M, et al. Indicators of fetal and infant health outcomes. Eur J Obstet Gynecol Reprod Biol 2003;111: S66-77
2. Moster D, Lie RT, Markestad T. Long-term medical and social consequences of preterm birth. N Engl J Med 2008;359:262-73
3. Jakobsson M, Gissler M, Paavonen J, Tapper AM. The incidence of preterm deliveries decreases in Finland. BJOG 2008;115:38-43
4. Martin JA, Kung HC, Mathews TJ, et al. Annual summary of vital statistics: 2006. Pediatrics 2008;121:788-801
5. Goldenberg RL, Culhane JF, Iams JD, Romero R. Epidemiology and causes of preterm birth. Lancet 2008;371:75-84
6. Mitchell MD, Romero RJ, Edwin SS, Trautman MS. Prostaglandins and parturition. Reprod Fertil Dev 1995;7:623-32
7. Woodworth A, Moore J, G'Sell C, et al. Diagnostic accuracy of cervicovaginal interleukin-6 and interleukin-6:albumin ratio as markers of preterm delivery. Clin Chem 2007;53:1534-40
8. Brik M, Antonio P, Perales-Puchalt A, et al. Cervical interleukin-6 as a predictive test for preterm delivery in symptomatic women: preliminary results. Eur J Obstet Gynecol Reprod Biol 2011;155: 14-8
9. Lange M, Chen FK, Wessel J, et al. Elevation of interleukin-6 levels in cervical secretions as a predictor of preterm delivery. Acta Obstet Gynecol Scand 2003;82:326-9
10. Coleman MAG, Keelan JA, McCowan LME, et al. Predicting preterm delivery: comparison of cervicovaginal interleukin (IL)-1b, IL-6 and IL-8 with fetal fibronectin and cervical dilatation. Eur J Obstet Gynecol Reprod Biol 2001;95:154-8
11. Steinberg DM, Fine J, Chappell R. Sample size for positive and negative predictive value in diagnostic research using case-control designs. Biostatistics 2009;10:94-105
12. Di Renzo GC, Roura LC, Facchinetti F, et al. Guidelines for the management of spontaneous preterm labor: identification of spontaneous preterm labor, diagnosis of preterm premature rupture of membranes, and preventive tools for preterm birth. J Matern Fetal Neonatal Med 2011;24:659-67
13. Kurkinen-Raty M, Ruokonen A, Vuopala S, et al. Combination of cervical interleukin-6 and -8, phosphorylated insulin-like growth factor-binding protein-1 and transvaginal cervical ultrasonography in assessment of the risk of preterm birth. BJOG 2001;108:875-81
14. Brik M, Hernandez AI, Pedraz CC, Perales A. Phosphorylated insulin-like growth factor binding protein-1 and cervical measurement in women with threatening preterm birth. Acta Obstet Gynecol Scand 2010;89:268-74
15. Domenech JM, Granero R. !ROC. Roc analysis (computer program). V2009.04.29. Bellaterra: Universitat Autonoma de Barcelona 2009. Available from: http://www.metodo.uab.cat/macros.htm [last accessed 20 Oct 2011]
16. Domenech JM. Macro!DT for SPSS Statistics. Diagnostic Tests (computer program). V2009.06.26. Bellaterra: Universitat Autonoma de Barcelona 2009. Available from: http://www.metodo. uab.cat/macros.htm [last accessed 20 Oct 2011]
17. Rose CH, McWeeney DT, Brost BC, et al. Cost-effective standardization of preterm labor evaluation. Am J Obstet Gynecol 2010;203:250 e1-5
18. Nassar AH, Aoun J, Usta IM. Calcium channel blockers for the management of preterm birth: a review. Am J Perinatol 2011;28: 57-66
19. Peltoniemi OM, Kari MA, Hallman M. Repeated antenatal corticosteroid treatment: a systematic review and meta-analysis. Acta Obstet Gynecol Scand 2011;90:719-27
20. Davis EP, Waffarn F, Uy C, et al. Effect of prenatal glucocorticoid treatment on size at birth among infants born at term gestation. J Perinatol 2009;29:731-7
21. Sood BG, Lulic-Botica M, Holzhausen KA, et al. The risk of necrotizing enterocolitis after indomethacin tocolysis. Pediatrics 2011;128:e54-62
22. Myles TD. Steroids - plenty of benefits, but not without risk. Obstet Gynecol 2011;117:429-30
23. Anotayanonth S, Subhedar NV, Garner P, et al. Betamimetics for inhibiting preterm labour. Cochrane Database Syst Rev 2004: CD004352
24. Honest H, Forbes CA, Duree KH, et al. Screening to prevent spontaneous preterm birth: systematic reviews of accuracy and effectiveness literature with economic modelling. Health Technol Assess 2009;13:1-627
25. Valentin L, Bergelin I. Intra- and interobserver reproducibility of ultrasound measurements of cervical length and width in the second and third trimesters of pregnancy. Ultrasound Obstet Gynecol 2002; 20:256-62
26. Woodworth A, Grenache DG, Gronowski AM. Cervicovaginal interleukin-6 as a predictor of preterm birth in African American women. Clin Chim Acta 2011;412:988-92
27. Sanchez-Ramos L, Delke I, Zamora J, Kaunitz AM. Fetal fibronectin as a short-term predictor of preterm birth in symptomatic patients: a meta-analysis. Obstet Gynecol 2009;114:631-40